# Oral Paricalcitol in Stage 3 - 5 Chronic Kidney Disease

> **NCT00796679** · NA · COMPLETED · sponsor: **The University of Hong Kong** · enrollment: 60 (actual)

## Conditions studied

- Chronic Kidney Disease

## Interventions

- **DRUG:** paricalcitol

## Key facts

- **NCT ID:** NCT00796679
- **Lead sponsor:** The University of Hong Kong
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-10
- **Primary completion:** 2011-06
- **Final completion:** 2011-06
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2017-01-10

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00796679

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00796679, "Oral Paricalcitol in Stage 3 - 5 Chronic Kidney Disease". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT00796679. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*